RDHL - RedHill Biopharma Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
6,060
8,360
4,007
101
Cost of Revenue
2,055
2,837
2,126
0
Gross Profit
4,005
5,523
1,881
101
Operating Expenses
Research Development
20,921
24,862
32,969
25,241
Selling General and Administrative
24,564
19,992
20,039
5,403
Total Operating Expenses
45,485
44,854
53,853
30,644
Operating Income or Loss
-41,480
-39,331
-51,972
-30,543
Interest Expense
-1,919
42
77
7
Total Other Income/Expenses Net
-
274
6,208
898
Income Before Tax
-38,297
-38,820
-45,544
-29,370
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-38,297
-38,820
-45,544
-29,370
Net Income
-38,297
-38,820
-45,544
-29,370
Net Income available to common shareholders
-38,297
-38,820
-45,544
-29,370
Reported EPS
Basic
-
-1.70
-2.60
-2.30
Diluted
-
-1.70
-2.60
-2.40
Weighted average shares outstanding
Basic
-
22,835
17,517
12,770
Diluted
-
22,835
17,517
12,770
EBITDA
-
-38,688
-45,386
-29,319